Patients diagnosed with syndrome X and hypertension may have microvascular angina characterized by a reduced coronary vasodilator reserve and increased sympathetic drive. ACE inhibition in such patients may attenuate sympathetic coronary vasoconstriction, normalize thallium perfusion defects and reduce exercise-induced ischemia with subsequent increased myocardial oxygen supply. Based on the recent AHA and ESC guidelines, the recommended goal blood pressure in patients with atherosclerotic coronary vascular disease is less than 130/80 mm Hg.
Chronic stable angina treatment angiotensin converting enzyme inhibitors 
Chronic stable angina treatment calcium channel blockers
Chronic stable angina treatment anti-lipid agents
Chronic stable angina treatment beta blockers
Chronic stable angina treatment aspirin
Chronic stable angina treatment dipyridamole
Chronic stable angina treatment potassium channel openers
Chronic stable angina treatment lipid management